Director Share Dealing

RNS Number : 8571B

Futura Medical PLC

09 April 2013

 



For immediate release

9 April 2013

Futura Medical plc 

("Futura" or "the Company")

Director Share Dealings

Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology, announces that it has received notification that Jonathan Freeman, the senior non-executive director of the Company, has today transferred 6,802 shares in the Company from certificated form in his name into his Crest account at Hargreaves Lansdown.

No disposal has taken place for the purposes of the AIM Rules for Companies. Mr Freeman's aggregate beneficial holding remains unchanged at 6,802 ordinary shares.

For any further information please contact:

Futura Medical plc
James Barder, Chief Executive	Tel: [phone]
mail to: [e-mail]	www.futuramedical.com
Nomura Code Securities Limited
Phil Walker / Giles Balleny	Tel:[phone]
For media enquiries please contact:
Buchanan
Mark Court / Fiona Henson / Sophie Cowles	Tel: [phone]

Notes to Editors

Futura Medical plc

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

www.futuramedical.com

 

END

 

 

RDSIPMFTMBIMBRJ